DNA O
elements O
recognizing O
NF B
- I
Y I
and O
Sp1 B
regulate O
the O
human B
multidrug I
- I
resistance I
gene I
promoter I
. O

Like O
other O
IAPs B
, O
ch B
- I
IAP1 I
contains O
the O
N B
- I
terminal I
baculovirus I
IAP I
repeats I
and O
C O
- O
terminal O
RING O
finger O
motifs O
. O

To O
test O
this O
hypothesis O
, O
we O
developed O
a O
system O
of O
transient O
transfection O
of O
rat O
adipocytes O
with O
constructs O
containing O
glyceraldehyde B
- I
3 I
- I
phosphate I
dehydrogenase I
( O
GAPDH B
) O
and O
fatty B
acid I
synthetase I
( O
FAS B
) O
promoters O
fused O
to O
gene B
reporter I
CAT I
. O

Studies O
of O
HS2 B
- I
gamma I
gene I
reporter I
constructs I
carrying O
CACCC O
box O
deletions O
revealed O
that O
the O
CACCC O
box O
sequence O
of O
the O
gamma O
gene O
promoter O
mediates O
the O
activation O
of O
the O
gamma O
gene O
by O
FKLF B
. O

Significant O
differences O
were O
observed O
in O
the O
composition O
of O
nuclear O
transcription O
factors O
bound O
to O
cis O
- O
elements O
within O
the O
LDH B
/ I
C I
proximal I
promoter I
region I
in O
somatic O
versus O
germ O
cells O
. O

SYC1 B
( O
suppressor B
of I
yeast I
cbf5 I
- I
1 I
) O
was O
identified O
as O
a O
multicopy O
suppressor O
of O
cbf5 B
- I
1 I
and O
subsequently O
was O
found O
to O
be O
identical O
to O
RRN3 B
, O
an O
RNA B
polymerase I
I I
transcription I
factor I
. O

The O
elevated O
levels O
of O
inositol O
phosphates O
resulting O
from O
N B
( I
epi I
) I
alpha I
qQ209L I
expression O
were O
similar O
to O
those O
obtained O
with O
carbachol O
activation O
of O
the O
M1 B
muscarinic I
acetylcholine I
receptor I
. O

At O
least O
one O
such O
complex O
is O
eliminated O
by O
preincubating O
the O
nuclear O
extract O
with O
an O
antibody O
with O
broad O
cross O
- O
reactivity O
with O
Ets B
- I
1 I
and O
Ets B
- I
2 I
proteins I
, O
thus O
confirming O
that O
an O
ETS B
transcription I
factor I
( I
s I
) I
recognizes O
the O
- O
12 O
motif O
. O

The O
preference O
for O
third O
base O
codon O
in O
Y O
position O
prolines O
is O
U O
for O
the O
alpha B
2 I
( I
VI I
) I
collagen I
as O
it O
is O
for O
the O
human B
fibrillar I
collagen I
genes I
. O

Recombinant O
protein O
encoded O
by O
ESX B
( O
for O
epithelial B
- I
restricted I
with I
serine I
box I
) O
exhibits O
Ets B
- I
like I
DNA O
binding O
specificity O
in O
electrophoretic O
mobility O
shift O
assays O
and O
, O
in O
transient O
transfection O
assays O
, O
transactivates O
Ets B
- I
responsive I
promoter I
elements I
including O
that O
found O
in O
the O
HER2 B
/ O
neu B
oncogene O
. O

Negative O
modulation O
of O
alpha1 B
( I
I I
) I
procollagen I
gene I
expression O
in O
human O
skin O
fibroblasts O
: O
transcriptional O
inhibition O
by O
interferon B
- I
gamma I
. O

We O
next O
developed O
a O
rapid O
purification O
method O
for O
bacterial B
recombinant I
MyoD I
- I
bHLH I
domain I
by O
affinity O
chromatography O
using O
a O
calmodulin B
- O
Sepharose O
column O
and O
investigated O
the O
phosphorylation O
of O
that O
peptide O
by O
PKC B
and O
its O
interactions O
with O
calmodulin B
and O
S100a B
. O

The O
interleukin B
- I
2 I
receptor I
alpha I
( O
IL B
- I
2R I
alpha I
) O
chain O
gene O
contains O
a O
sequence O
similar O
to O
the O
immunoglobulin B
( I
Ig I
) I
kappa I
( O
kappa O
) O
enhancer O
NF B
- I
kappa I
B I
binding I
site I
. O

Anti B
- I
Jo I
- I
1 I
antibody I
was O
not O
present O
. O

Its O
phosphorylation O
strongly O
potentiates O
its O
ability O
to O
activate O
transcription O
of O
the O
c B
- I
fos I
promoter I
through O
a O
ternary O
complex O
assembled O
on O
the O
c B
- I
fos I
serum I
response I
element I
. O

The O
prosomal B
RNA I
- I
binding I
protein I
p27K I
is O
a O
member O
of O
the O
alpha B
- I
type I
human I
prosomal I
gene I
family I
. O

Analysis O
of O
the O
5 O
' O
and O
3 O
' O
termini O
of O
the O
transcripts O
produced O
in O
vivo O
from O
the O
puf B
operon I
of I
R I
. I
sphaeroides I
PUF B
delta I
348 I
- I
420 I
( O
three O
transcripts O
; O
0 O
. O
59 O
, O
0 O
. O
64 O
, O
and O
2 O
. O
63 O
kilobases O
) O
lacking O
the O
puf O
- O
intercistronic O
terminator O
structure O
were O
identical O
to O
those O
of O
the O
corresponding O
puf B
transcripts I
derived O
from O
wild O
- O
type O
R O
. O
sphaeroides O
2 O
. O
4 O
. O
1 O
( O
four O
transcripts O
; O
0 O
. O
50 O
, O
0 O
. O
66 O
, O
0 O
. O
71 O
, O
and O
2 O
. O
7 O
kilobases O
) O
showing O

Four O
families O
of O
homing B
endonucleases I
have O
been O
identified O
, O
including O
the O
LAGLIDADG B
, O
the O
His B
- I
Cys I
box I
, O
the O
GIY B
- I
YIG I
and O
the O
H B
- I
N I
- I
H I
endonucleases I
. O

The O
delta O
Mo O
+ O
SV O
tumor O
DNAs O
from O
B O
- O
lineage O
tumors O
were O
typically O
rearranged O
at O
the O
immunoglobulin B
gene I
loci I
and O
contained O
germ O
line O
configurations O
of O
the O
T B
- I
cell I
receptor I
beta I
gene I
. O

The O
tam B
A I
gene I
of I
Aspergillus I
nidulans I
encodes O
a O
739 O
- O
amino O
acid O
protein O
with O
similarity O
to O
Uga35p B
/ O
Dal81p B
/ O
DurLp B
of O
Saccharomyces O
cerevisiae O
. O

The O
predicted O
proteins O
show O
strong O
homology O
to O
an O
ABA B
- I
inducible I
glycine I
- I
rich I
protein I
from O
maize O
embryos O
and O
to O
the O
mammalian B
RNA I
- I
binding I
protein I
A1 I
of O
the O
heterogeneous O
nuclear O
ribonucleoprotein O
complex O
involved O
in O
pre O
- O
mRNA O
splicing O
. O

The O
glyoxysomal O
and O
plastid O
molecular O
chaperones O
( O
70 B
- I
kDa I
heat I
shock I
protein I
) O
of O
watermelon O
cotyledons O
are O
encoded O
by O
a O
single O
gene O
. O

In O
vitro O
DNA O
binding O
assays O
indicate O
that O
the O
elements O
identified O
can O
specifically O
interact O
with O
c B
- I
Ets I
- I
1 I
protein I
. O

The O
chicken O
genome O
contains O
two O
functional O
nonallelic O
beta1 B
, I
4 I
- I
galactosyltransferase I
genes I
. O

Sequences O
within O
the O
UAS2 O
element O
of O
the O
ENO2 B
gene I
bound O
a O
second O
protein O
which O
corresponded O
to O
the O
ABFI B
( O
autonomously B
replicating I
sequence I
- I
binding I
factor I
) O
protein O
. O

In O
this O
report O
, O
we O
identify O
Tyr319 O
as O
a O
functionally O
important O
phosphorylation O
site O
in O
the O
ZAP B
- I
70 I
interdomain I
B I
region I
. O

Molecular O
cloning O
of O
cDNAs O
encoding O
alpha O
- O
subunits O
of O
guanine B
nucleotide I
- I
binding I
regulatory I
proteins I
( O
G B
- I
proteins I
) O
has O
revealed O
the O
existence O
of O
nine O
species O
of O
alpha O
- O
subunits O
. O

TNF B
- I
alpha I
effect O
was O
eliminated O
by O
a O
2 O
- O
bp O
substitution O
mutation O
in O
the O
NF B
- I
kappa I
B1 I
binding I
half I
site I
of O
the O
NF B
- I
kappa I
B I
cis I
element I
. O

The O
RAG B
- I
2 I
gene I
encodes O
a O
component O
of O
the O
V B
( I
D I
) I
J I
recombinase I
which O
is O
essential O
for O
the O
assembly O
of O
antigen O
receptor O
genes O
in O
B O
and O
T O
lymphocytes O
. O

Sucrose O
- O
specific O
signalling O
represses O
translation O
of O
the O
Arabidopsis B
ATB2 I
bZIP I
transcription I
factor I
gene I
. O

Like O
the O
human O
gene O
, O
the O
Drosophila O
gene O
encodes O
at O
least O
three O
isoforms O
of O
full B
length I
dystrophin I
- I
like I
proteins I
( O
dmDLP1 B
, O
dmDLP2 B
and O
dmDLP3 B
, O
) O
, O
regulated O
by O
different O
promoters O
located O
at O
the O
5 O
' O
end O
of O
the O
gene O
, O
and O
a O
smaller O
product O
regulated O
by O
an O
internal O
promoter O
( O
dmDp186 B
) O
. O

When O
a O
longer O
- O
714 O
to O
+ O
78 O
fragment O
of O
the O
PBGD B
promoter I
is O
used O
, O
the O
- O
70 O
GATA O
mutant O
still O
displays O
erythroid O
- O
specific O
activity O
and O
is O
cis O
- O
activated O
by O
the O
5 B
' I
HS I
- I
2 I
enhancer I
, O
while O
the O
- O
100 O
CCACC O
mutant O
is O
completely O
inactive O
in O
the O
absence O
or O
in O
the O
presence O
of O
the O
5 B
' I
HS I
- I
2 I
enhancer I
. O

When O
a O
longer O
- O
714 O
to O
+ O
78 O
fragment O
of O
the O
PBGD B
promoter I
is O
used O
, O
the O
- O
70 O
GATA O
mutant O
still O
displays O
erythroid O
- O
specific O
activity O
and O
is O
cis O
- O
activated O
by O
the O
5 B
' I
HS I
- I
2 I
enhancer I
, O
while O
the O
- O
100 O
CCACC O
mutant O
is O
completely O
inactive O
in O
the O
absence O
or O
in O
the O
presence O
of O
the O
5 B
' I
HS I
- I
2 I
enhancer I
. O

This O
mutant O
also O
functions O
in O
vivo O
as O
a O
trans O
- O
acting O
dominant O
negative O
regulator O
: O
the O
transcriptional O
inducibility O
of O
the O
HIV B
long I
terminal I
repeat I
( O
which O
contains O
two O
potential O
NF B
- I
kappa I
B I
binding I
sites I
) O
by O
phorbol O
ester O
( O
PMA O
) O
is O
inhibited O
when O
it O
is O
co O
- O
transfected O
into O
CD4 B
+ I
T O
cells O
with O
the O
delta O
SP O
mutant O
. O

However O
, O
coligation O
of O
Fc B
gamma I
RIIB1 I
with O
B B
cell I
Ag I
receptors I
( O
BCR B
) O
inhibits O
BCR B
- O
mediated O
signaling O
by O
a O
mechanism O
that O
may O
involve O
recruitment O
of O
phosphatases B
SHP I
- I
1 I
, O
SHP B
- I
2 I
, O
and O
the O
SH2 B
containing I
inositol I
5 I
' I
phosphatase I
( O
SHIP B
) O
to O
the O
phosphorylated O
Fc B
gamma I
RIIB1 I
immunoreceptor I
tyrosine I
- I
based I
inhibitory I
motif I
. O

The O
corresponding O
tetrapeptide O
sequences O
SSPD O
and O
SATD O
for O
human B
and I
mouse I
PKC I
- I
epsilon I
, O
respectively O
, O
are O
unusual O
for O
caspase B
- I
3 I
. O

80 O
v B
- I
ets I
- O
encoded O
amino O
- O
acids O
located O
immediately O
after O
the O
v B
- I
myb I
/ O
v B
- I
ets I
junction O
are O
not O
found O
in O
P54 B
/ O
56c B
- I
ets I
, O
the O
translation O
product O
of O
the O
c B
- I
ets I
proto I
- I
oncogene I
, O
nor O
in O
a O
set O
of O
cellular O
proteins O
of O
64 O
, O
62 O
, O
and O
60 O
kDa O
related O
to O
but O
distinct O
from O
P54 B
/ O
56c B
- I
ets I
. O

The O
Synechococcus B
gene I
rps1 I
encoding O
S1 B
is O
located O
1 O
. O
1 O
kb O
downstream O
from O
psbB B
, O
which O
encodes O
the O
photosystem B
II I
P680 I
chlorophyll I
a I
apoprotein I
. O

Low O
- O
affinity O
E2 B
- I
binding I
site I
mediates O
downmodulation O
of O
E2 B
transactivation O
of O
the O
human B
papillomavirus I
type I
8 I
late I
promoter I
. O

Signal O
transduction O
in O
fibroblasts O
stably O
transformed O
by O
[ O
Val12 O
] O
Ras O
- O
- O
the O
activities O
of O
extracellular B
- I
signal I
- I
regulated I
kinase I
and O
Jun B
N I
- I
terminal I
kinase I
are O
only O
moderately O
increased O
, O
and O
the O
activity O
of O
the O
delta O
- O
inhibitor O
of O
c B
- I
Jun I
is O
not O
alleviated O
. O

Here O
we O
report O
the O
cloning O
of O
the O
hemF B
gene I
, O
encoding O
the O
aerobic O
coproporphyrinogen B
III I
oxidase I
from I
Escherichia I
coli I
, O
by O
functional O
complementation O
of O
a O
Saccharomyces B
cerevisiae I
HEM13 I
mutant I
. O

The O
present O
study O
demonstrates O
that O
the O
proto B
- I
oncogene I
c I
- I
jun I
represses O
transcription O
of O
the O
human B
CG I
alpha I
and O
CG B
beta I
promoters I
. O

c B
- I
Jun I
repressed O
the O
CG B
alpha I
promoter I
through O
a O
canonical O
cAMP O
response O
element O
( O
CRE O
) O
that O
is O
known O
to O
bind O
c B
- I
Jun I
and O
other O
members O
of O
the O
B B
- I
Zip I
transcription I
factor I
family I
. O

Cloning O
and O
characterization O
of O
the O
5 O
' O
flanking O
region O
of O
human B
ATP I
- I
citrate I
lyase I
gene I
. O

The O
nucleotide O
sequence O
of O
the O
estrogen B
receptor I
gene I
of I
Oreochromis I
aureus I
( O
OaER B
) O
indicates O
that O
the O
hormone O
- O
binding O
E O
domain O
is O
composed O
of O
4 O
exons O
interspersed O
by O
short O
introns O
of O
only O
0 O
. O
18 O
- O
1 O
. O
3 O
kb O
each O
. O

However O
, O
ADAR1 B
and O
the O
related O
deaminase B
ADAR2 I
showed O
significant O
expression O
in O
all O
regions O
of O
the O
brain O
examined O
, O
including O
cortex O
, O
hippocampus O
, O
olfactory O
bulb O
, O
and O
striatum O
, O
where O
the O
5 B
- I
HT2CR I
pre I
- I
mRNA I
was O
extensively O
edited O
. O

Helenalin O
triggers O
a O
CD95 B
death I
receptor I
- O
independent O
apoptosis O
that O
is O
not O
affected O
by O
overexpression O
of O
Bcl B
- I
x I
( I
L I
) I
or O
Bcl B
- I
2 I
. O

V B
- I
ErbB I
- I
mediated I
complex I
formation O
and O
transformation O
have O
been O
shown O
to O
occur O
independently O
of O
Ras B
activation O
. O

PrRP B
rapidly O
and O
transiently O
activated O
extracellular B
signal I
- I
regulated I
protein I
kinase I
( O
ERK B
) O
in O
both O
types O
of O
cells O
. O

This O
sequence O
can O
interact O
with O
at O
least O
two O
proteins O
in O
a O
fibroblast O
nuclear O
extract O
that O
have O
binding O
characteristics O
of O
an O
Ets B
family I
protein I
and O
a O
serum B
response I
factor I
- I
like I
protein I
. O

As O
much O
thrombin B
was O
formed O
during O
cardiopulmonary O
bypass O
( O
measured O
by O
the O
prothrombin B
activation I
fragment I
F1 I
+ I
2 I
and O
thrombin B
- O
antithrombin B
complexes O
) O
as O
in O
normal O
patients O
, O
showing O
that O
factor B
XII I
was O
not O
necessary O
for O
thrombin B
generation O
. O

MUS81 B
encodes O
a O
novel O
helix B
- I
hairpin I
- I
helix I
protein I
involved O
in O
the O
response O
to O
UV O
- O
and O
methylation O
- O
induced O
DNA O
damage O
in O
Saccharomyces O
cerevisiae O
. O

In O
vitro O
binding O
studies O
previously O
showed O
that O
NF B
- I
kappa I
B I
p50 B
homodimer O
binds O
the O
switch B
nuclear I
B I
- I
site I
protein I
( O
SNIP B
) O
of O
the O
S B
gamma I
3 I
tandem I
repeat I
. O

This O
was O
further O
suggested O
by O
transactivation O
assays O
in O
which O
mouse O
fibroblasts O
were O
transiently O
transfected O
with O
a O
human B
beta I
- I
globin I
reporter I
gene I
in O
the O
absence O
and O
presence O
of O
an O
LKLF B
cDNA I
construct I
. O

In O
EGF B
receptor I
- O
mediated O
signaling O
, O
the O
protein B
kinase I
PKB I
/ O
Akt B
and O
the O
mitogen B
- I
activated I
protein I
kinase I
c I
- I
Jun I
N I
- I
terminal I
kinase I
, O
but O
not O
extracellular B
signal I
- I
regulated I
kinase I
2 I
, O
function O
downstream O
of O
phosphatidylinositol B
3 I
- I
kinase I
( O
PI B
3 I
- I
kinase I
) O
. O

In O
this O
study O
, O
we O
report O
the O
cloning O
and O
sequencing O
of O
several O
overlapping O
cDNAs O
encoding O
approximately O
4 O
. O
1 O
kb O
of O
the O
human B
homologue I
of I
Wnt I
- I
5A I
. O

In O
normal O
B O
cells O
stimulated O
by O
LPS O
or O
IL B
- I
4 I
, O
new O
complexes O
appear O
that O
bind O
to O
C B
/ I
EBP I
and O
NF B
- I
IL I
- I
4 I
elements I
, O
respectively O
, O
located O
within O
the O
- O
125 O
/ O
- O
101 O
region O
. O

The O
amino O
acid O
sequence O
of O
the O
protein O
encoded O
by O
MSK1 B
is O
homologous O
to O
yeast B
cytoplasmic I
lysyl I
- I
tRNA I
synthetase I
and O
to O
the O
product O
of O
the O
herC B
gene I
, O
which O
has O
recently O
been O
suggested O
to O
code O
for O
the O
Escherichia O
coli O
enzyme O
. O

The O
recombinant B
L I
/ I
F I
- I
transferase I
is O
as O
active O
as O
the O
previously O
purified O
wild O
type O
enzyme O
and O
contains O
no O
detectable O
RNA O
component O
. O

The O
virus O
must O
progress O
past O
the O
immediate O
- O
early O
phase O
and O
express O
an O
early B
gene I
product I
( I
s I
) I
for O
activation O
of O
cyclin B
E I
expression O
. O

Treatment O
of O
JEA2 O
cells O
with O
interleukin B
( I
IL I
) I
- I
7 I
induces O
CBLB B
phosphorylation O
as O
well O
. O

To O
study O
the O
mechanisms O
and O
the O
signaling O
pathways O
involved O
, O
IGF B
- I
1R I
promoter I
reporter I
constructs I
were O
transiently O
transfected O
in O
CHO O
- O
AT1 O
cells O
that O
overexpress O
angiotensin B
AT1 I
receptors I
. O

Promoter O
region O
of O
the O
human B
alpha I
2A I
adrenergic I
receptor I
gene I
. O

DNMT2 B
binds O
AdoHcy O
in O
the O
same O
conformation O
as O
confirmed O
m B
( I
5 I
) I
C I
MTases I
and O
, O
while O
DNMT2 B
shares O
all O
sequence O
and O
structural O
features O
with O
m B
( I
5 I
) I
C I
MTases I
, O
it O
has O
failed O
to O
demonstrate O
detectable O
transmethylase O
activity O
. O

DNMT2 B
binds O
AdoHcy O
in O
the O
same O
conformation O
as O
confirmed O
m B
( I
5 I
) I
C I
MTases I
and O
, O
while O
DNMT2 B
shares O
all O
sequence O
and O
structural O
features O
with O
m B
( I
5 I
) I
C I
MTases I
, O
it O
has O
failed O
to O
demonstrate O
detectable O
transmethylase O
activity O
. O

Consistent O
with O
this O
hypothesis O
, O
stimulation O
of O
A B
( I
2A I
) I
- I
R I
or O
PKA B
enhanced O
nuclear B
aPKC I
activity O
. O

The O
mouse B
alpha I
A I
- I
CRYBP1 I
gene I
specifies O
a O
2 O
, O
688 O
- O
amino O
acid O
protein O
with O
72 O
% O
amino O
acid O
identity O
to O
its O
human O
homologue O
, O
PRDII B
- I
BF1 I
. O

Furthermore O
, O
we O
have O
identified O
the O
major O
open O
reading O
frame O
( O
RF4 O
; O
2 O
. O
3 O
kb O
) O
as O
being O
essential O
for O
activation O
, O
and O
we O
have O
shown O
that O
the O
NF B
kappa I
B I
, O
SP1 B
, O
and O
TATA O
box O
motifs O
in O
the O
human B
immunodeficiency I
virus I
LTR I
are O
all O
required O
for O
full O
induction O
of O
the O
promoter O
by O
the O
HHV B
- I
6 I
- I
encoded I
transactivator I
. O

The O
cloned O
rRNA O
operon O
was O
transcribed O
in O
vitro O
by O
using O
purified B
RNA I
polymerase I
of I
Escherichia I
coli I
. O

Using O
probes O
containing O
C B
/ I
EBP I
- I
binding I
sites I
from O
the O
iNOS B
gene I
revealed O
further O
binding O
of O
different O
complexes O
, O
all O
of O
which O
were O
strongly O
inducible O
by O
cAMP O
and O
to O
a O
lower O
extent O
also O
by O
IL B
- I
1beta I
. O

METHODS O
: O
The O
prevalence O
of O
haemagglutination B
inhibiting I
( I
HI I
) I
antibodies I
to O
JE O
virus O
( O
JEV O
) O
, O
West O
Nile O
virus O
( O
WNV O
) O
and O
dengue O
- O
2 O
virus O
( O
DEN O
- O
2 O
) O
was O
detected O
by O
HI O
test O
and O
IgM B
antibody I
capture O
ELISA O
( O
MAC O
ELISA O
) O
was O
performed O
to O
determine O
recent O
infections O
with O
JE O
virus O
. O

A O
Drosophila O
subobscura O
genomic O
fragment O
containing O
all O
the O
exons O
and O
the O
late O
and O
early O
promotors O
in O
the O
Sxl B
gene I
of I
D I
. I
melanogaster I
was O
isolated O
. O

We O
propose O
2 O
separate O
PAI B
- I
1 I
inductory O
pathways O
for O
PMA O
and O
IL B
- I
1alpha I
in O
HepG2 O
, O
both O
involving O
protein B
tyrosine I
kinase I
activation O
; O
the O
serum O
- O
induced O
signaling O
pathway O
may O
( O
partially O
) O
overlap O
with O
the O
PMA O
- O
activated O
protein B
kinase I
C I
/ O
mitogen B
- I
activated I
protein I
kinase I
kinase I
pathway O
, O
leading O
to O
c B
- I
Jun I
homodimer I
binding O
to O
the O
PAI B
- I
1 I
TRE O
. O

Activation O
of O
the O
mitogen B
- I
activated I
protein I
kinase I
( O
MAPK B
) O
pathway O
enhances O
long O
- O
range O
transactivation O
by O
the O
beta B
- I
globin I
locus I
control I
region I
( O
LCR O
) O
( O
W O
. O

Six O
cDNAs O
represent O
human O
homologs O
of O
genes O
known O
in O
other O
species O
, O
namely O
, O
mouse B
HSPE71 I
, O
Rat B
RhoGAP I
protein I
, O
S B
cerevisiae I
leucyl I
tRNA I
synthetase I
and O
S B
cerevisiae I
chromosome I
II I
ORF I
YBLO44W I
. O

In O
addition O
, O
we O
found O
that O
the O
transactivation O
mediated O
by O
the O
p68c B
- I
ets I
- I
1 I
pr I
p55erg B
through O
the O
Polyomavirus B
enhancer I
sequence I
is O
specifically O
inhibited O
by O
the O
p46kDaPax B
- I
QNR I
in O
transient O
transfection O
assay O
. O

The O
Grb2 B
SH3 B
( I
C I
) I
binding I
region I
of O
Gab1 B
has O
significant O
homology O
to O
a O
region O
of O
the O
adapter B
protein I
SLP I
- I
76 I
. O

Analysis O
of O
1 O
Mb O
of O
published O
sequence O
from O
the O
region O
of O
conserved O
synteny O
on O
human O
chromosome O
5q31 O
- O
q33 O
identified O
45 O
gene O
candidates O
, O
including O
35 O
expressed O
genes O
in O
the O
human B
IL I
- I
4 I
cytokine I
gene I
cluster O
. O

A O
rare O
tRNA B
- I
Arg I
( I
CCU I
) I
that O
regulates O
Ty1 B
element I
ribosomal O
frameshifting O
is O
essential O
for O
Ty1 B
retrotransposition O
in O
Saccharomyces O
cerevisiae O
. O

Sin4 B
and O
Srb10 B
, O
components O
of O
specific O
RNA B
polymerase I
II I
sub I
- I
complexes I
that O
are O
required O
for O
Ssn6 B
- O
Tup1 B
repression O
activity O
, O
are O
found O
to O
be O
required O
for O
Sfl1 B
repression O
function O
. O

To O
explore O
the O
mechanism O
of O
insulin B
receptor I
phosphorylation O
we O
have O
used O
NIH3T3 O
cells O
transfected O
with O
two O
receptor O
constructs O
: O
one O
encoding O
a O
chimeric O
receptor O
composed O
of O
the O
extracellular O
domain O
of O
the O
human B
EGF I
receptor I
and O
the O
cytosolic O
domain O
of O
the O
human B
insulin I
receptor I
beta I
- I
subunit I
, O
and O
a O
second O
construct O
encoding O
a O
kinase O
- O
defiecient O
human B
insulin I
receptor I
. O

SF1 B
/ O
mBBP B
utilizes O
a O
" B
maxi I
- I
K I
homology I
" I
( O
maxi B
- I
KH I
) O
domain O
for O
recognition O
of O
the O
single O
- O
stranded O
BPS O
and O
requires O
a O
cooperative O
interaction O
with O
splicing O
factor O
U2AF65 B
bound O
to O
an O
adjacent O
polypyrimidine O
tract O
( O
PPT O
) O
for O
high O
- O
affinity O
binding O
. O

Analysis O
of O
pseudo B
VH I
gene I
segment I
recombination I
products I
reveals O
no O
bias O
in O
D B
gene I
segment I
reading O
frame O
utilization O
. O

In O
NIH O
3T3 O
fibroblasts O
the O
high O
affinity O
IL B
- I
2R I
bearing O
a O
deletion O
of O
a O
region O
rich O
in O
acidic O
amino O
acids O
( O
the O
" O
acidic O
" O
region O
) O
in O
the O
IL B
- I
2R I
beta I
- I
chain I
failed O
to O
induce O
the O
tyrosine O
phosphorylation O
of O
MAP B
kinase I
as O
well O
as O
the O
expression O
of O
the O
all O
three O
nuclear O
proto O
- O
oncogenes O
. O

Members O
of O
the O
steroid B
/ I
hormone I
nuclear I
receptor I
superfamily I
regulate O
target O
gene O
transcription O
via O
recognition O
and O
association O
with O
specific O
cis O
- O
acting O
sequences O
of O
DNA O
, O
called O
hormone O
response O
elements O
( O
HREs O
) O
. O

We O
have O
isolated O
two O
H19 B
cDNAs I
( O
AP B
and O
ES B
) O
that O
contain O
this O
ORF4 O
and O
correspond O
to O
incomplete O
copies O
of O
the O
unique O
2 B
. I
3 I
kb I
H19 I
RNA I
. O

The O
deduced O
gene O
product O
was O
found O
to O
have O
significant O
sequence O
similarity O
to O
the O
yeast B
and I
prokaryotic I
RNA I
polymerase I
subunits I
involved O
with O
subunit O
assembly O
. O

Because O
the O
wa B
- I
2 I
mutation I
was O
mapped O
previously O
to O
the O
vicinity O
of O
the O
EGF B
/ I
TGF I
- I
alpha I
receptor I
( O
EGFR B
) O
gene O
on O
mouse O
chromosome O
11 O
, O
we O
hypothesized O
that O
the O
wa B
- I
2 I
phenotype I
might O
result O
from O
a O
defect O
in O
either O
the O
expression O
or O
activity O
of O
EGFR B
, O
or O
both O
. O

The O
RHO1 B
gene I
encodes O
a O
homolog O
of O
the O
mammalian O
RhoA B
small I
GTP I
- I
binding I
protein I
in O
the O
yeast O
Saccharomyces O
cerevisiae O
. O

The O
human B
CA11 I
gene I
appears O
to O
be O
located O
between O
the O
secretor B
type I
alpha I
( I
1 I
, I
2 I
) I
- I
fucosyltransferase I
gene I
cluster I
( O
FUT1 B
- O
FUT2 B
- O
FUT2P B
) O
and O
the O
D B
- I
site I
binding I
protein I
gene I
( O
DBP B
) O
on O
chromosome O
19q13 O
. O
3 O
. O

The O
two O
yeast B
pheromone I
receptors I
, O
the O
a B
and I
alpha I
- I
factor I
receptors I
, O
share O
many O
functional O
similarities O
: O
both O
G B
protein I
- I
coupled I
receptors I
couple O
to O
the O
same O
downstream O
signal O
transduction O
pathway O
, O
and O
both O
receptors O
undergo O
feedback O
regulation O
involving O
increased O
phosphorylation O
on O
their O
C O
- O
terminal O
domains O
in O
response O
to O
ligand O
challenge O
. O

The O
c B
- I
Jun I
delta I
- I
domain I
inhibits O
neuroendocrine O
promoter O
activity O
in O
a O
DNA O
sequence O
- O
and O
pituitary O
- O
specific O
manner O
. O

The O
liver O
- O
specific O
sequence O
contains O
unique O
consensus O
sites O
for O
phosphorylation O
by O
cyclic B
AMP I
- I
dependent I
protein I
kinase I
and O
by O
protein B
kinase I
C I
. O

The O
Valpha B
and O
Vbeta B
domains I
have O
the O
canonical O
features O
of O
known O
teleost B
and I
mammalian I
TCR I
V I
domains I
, O
including O
conserved O
residues O
in O
the O
beginning O
of O
FR2 B
and O
at O
the O
end O
of O
FR3 B
. O

Growth O
factors O
promote O
cell O
survival O
through O
phosphorylation O
of O
Bad B
, O
resulting O
in O
its O
dissociation O
from O
Bcl B
- I
2 I
and O
Bcl B
- I
x I
( I
L I
) I
and O
its O
association O
with O
14 B
- I
3 I
- I
3tau I
. O

The O
herpesvirus B
entry I
mediator I
C I
( O
HveC B
) O
, O
previously O
known O
as O
poliovirus B
receptor I
- I
related I
protein I
1 I
( O
PRR1 B
) O
, O
and O
the O
herpesvirus B
Ig I
- I
like I
receptor I
( O
HIgR B
) O
are O
the O
bona O
fide O
receptors O
employed O
by O
herpes O
simplex O
virus O
- O
1 O
and O
- O
2 O
( O
HSV O
- O
1 O
and O
- O
2 O
) O
for O
entry O
into O
the O
human O
cell O
lines O
most O
frequently O
used O
in O
HSV O
studies O
. O

We O
have O
generated O
transgenic O
fly O
strains O
with O
mutations O
affecting O
specific O
TRA B
- I
2 I
isoforms I
to O
investigate O
their O
individual O
roles O
in O
regulating O
the O
alternative O
processing O
of O
doublesex B
, O
exuperantia B
and O
tra B
- I
2 I
pre I
- I
mRNA I
. O

However O
, O
the O
sequence O
of O
mRAR B
- I
beta I
3 I
region I
A I
differs O
from O
that O
of O
mRAR B
- I
beta I
1 I
by O
an O
additional O
27 O
C O
- O
terminal O
amino O
acids O
encoded O
in O
an O
81 O
nucleotide O
- O
long O
putative O
exon O
which O
is O
spliced O
in O
between O
the O
exons O
encoding O
the O
A B
and I
B I
regions I
of I
mRAR I
- I
beta I
1 I
. O

In O
cells O
stably O
transfected O
with O
G B
alpha I
i I
- I
2 I
or O
G B
alpha I
i I
- I
3 I
gene I
5 O
' O
- O
flanking O
sequences O
fused O
to O
firefly O
luciferase B
cDNA O
reporter O
, O
temporal O
10 O
- O
15 O
- O
fold O
transcriptional O
activation O
of O
both O
genes O
occurred O
before O
cellular O
polarization O
. O

Database O
searches O
revealed O
a O
50 O
- O
63 O
% O
similarity O
and O
34 O
- O
42 O
% O
identity O
with O
several O
families O
of O
serine B
proteases I
, O
in O
particular O
the O
trypsin B
- I
like I
proteases I
, O
members O
of O
the O
glandular B
kallikrein I
family I
( O
including O
prostate B
- I
specific I
antigen I
, O
nerve B
growth I
factor I
gamma I
, O
and O
epidermal B
growth I
factor I
- I
binding I
protein I
) O
and O
the O
activators O
for O
the O
kringle B
family I
proteins I
( O
including O
the O
human B
tissue I
plasminogen I
activator I
and O
human B
hepatocyte I
growth I
factor I
activator I
) O
. O

This O
result O
is O
consistent O
with O
the O
previous O
observation O
that O
expression O
of O
the O
hsp70 B
genes I
in I
T I
. I
brucei I
is O
mainly O
controlled O
at O
the O
posttranscriptional O
level O
. O

Restricted O
expression O
of O
a O
novel O
murine B
atonal I
- I
related I
bHLH I
protein I
in O
undifferentiated O
neural O
precursors O
. O

We O
report O
the O
genomic O
organization O
of O
the O
mouse O
orphan B
receptor I
related I
to I
tyrosine I
kinases I
( O
Ryk B
) O
, O
a O
structurally O
unclassified O
member O
of O
the O
growth B
factor I
receptor I
family O
. O

E O
. O
granulosus O
infection O
has O
been O
confirmed O
in O
25 O
patients O
( O
20 O
. O
6 O
% O
) O
, O
in O
16 O
cases O
by O
finding O
parasite O
protoscoleces O
or O
hooks O
and O
in O
nine O
cases O
by O
detection O
of O
an O
antigen O
specific O
for O
E B
. I
granulosus I
, I
antigen I
5 I
( O
Ag5 B
) O
. O

Comparison O
of O
the O
sequences O
of O
the O
alpha B
- I
like I
DNA I
polymerases I
including O
E B
. I
coli I
DNA I
polymerase I
II I
showed O
that O
there O
were O
nine O
highly O
conserved O
regions O
, O
and O
we O
constructed O
an O
unrooted O
phylogenetic O
tree O
of O
the O
DNA B
polymerases I
based O
on O
the O
differences O
in O
these O
conserved O
regions O
. O

We O
have O
introduced O
the O
same O
change O
in O
a O
yeast B
tRNA I
( I
Trp I
) I
gene I
and O
demonstrated O
that O
the O
tRNA O
acts O
as O
an O
efficient O
amber O
suppressor O
in O
vivo O
. O

The O
atf1 B
+ I
gene I
of I
Schizosaccharomyces I
pombe I
encodes O
a O
bZIP B
transcription I
factor I
with O
strong O
homology O
to O
the O
mammalian B
factor I
ATF I
- I
2 I
. O

Regulation O
of O
activating B
transcription I
factor I
- I
1 I
and O
the O
cAMP B
response I
element I
- I
binding I
protein I
by O
Ca2 B
+ I
/ I
calmodulin I
- I
dependent I
protein I
kinases I
type I
I I
, I
II I
, I
and I
IV I
. O

The O
promoter O
for O
HMG B
- I
CoA I
synthase I
contains O
two O
binding O
sites O
for O
the O
sterol B
regulatory I
element I
- I
binding I
proteins I
( O
SREBPs B
) O
. O

Suppression O
of O
the O
cka1 B
delta I
cka2 I
- I
8 I
mutant I
phenotype O
occurs O
by O
interaction O
of O
CKB1 B
with O
the O
defective O
, O
cka2 B
- I
8 I
- O
encoded O
, O
catalytic O
subunit O
. O

MsEPV O
genes O
with O
putative O
functions O
in O
prevention O
and O
repair O
of O
DNA O
damage O
include O
a O
complete O
base O
excision O
repair O
pathway O
( O
uracil B
DNA I
glycosylase I
, O
AP B
endonuclease I
, O
DNA B
polymerase I
beta I
, O
and O
an O
NAD B
+ I
- I
dependent I
DNA I
ligase I
) O
, O
a O
photoreactivation O
repair O
pathway O
( O
cyclobutane B
pyrimidine I
dimer I
photolyase I
) O
, O
a O
LINE B
- I
type I
reverse I
transcriptase I
, O
and O
a O
mutT B
homologue I
. O

We O
report O
the O
cloning O
of O
the O
ade1 B
gene I
on O
a O
4 B
. I
4 I
kb I
Sau3A I
insert I
in O
the O
yeast O
shuttle O
vector O
pWH5 O
. O

A O
selectable O
marker O
for O
transformation O
was O
constructed O
by O
transcriptional O
fusion O
of O
a O
Ustilago B
maydis I
heat I
shock I
gene I
promoter I
with O
the O
hygromycin B
B I
phosphotransferase I
gene I
of I
Escherichia I
coli I
. O

The O
Thrombolysis O
in O
Myocardial O
Infarction O
( O
TIMI O
) O
Phase O
II O
Trial O
randomized O
3 O
, O
339 O
patients O
to O
either O
an O
invasive O
( O
INV O
, O
n O
= O
1 O
, O
681 O
) O
or O
a O
conservative O
( O
CON O
, O
n O
= O
1 O
, O
658 O
) O
strategy O
after O
intravenous O
recombinant B
tissue I
- I
type I
plasminogen I
activator I
( O
rt B
- I
PA I
) O
for O
acute O
myocardial O
infarction O
. O

Also O
, O
residues O
273 O
to O
287 O
, O
which O
are O
identical O
in O
sequence O
to O
a O
15 O
- O
amino O
- O
acid O
segment O
near O
the O
carboxy O
terminus O
of O
the O
simian B
foamy I
virus I
transcriptional I
activator I
Taf I
, O
can O
independently O
enhance O
the O
activity O
of O
the O
minimal O
activator O
region O
. O

Characterization O
of O
the O
chromosome O
19 O
breakpoint O
region O
revealed O
that O
the O
transcription B
factor I
- I
encoding I
USF2 I
gene I
is O
affected O
. O

The O
c B
- I
raf I
- I
1 I
proto I
- I
oncogene I
is O
the O
cellular B
homologue I
of I
v I
- I
raf I
, O
the O
oncogene O
of O
the O
acutely O
transforming O
retrovirus O
3611 O
- O
MSV O
. O

Pax B
- I
6 I
constructs O
lacking O
the O
C O
- O
terminal O
activation O
domain O
repressed O
betaB1 B
- I
crystallin I
promoter I
activity O
as O
effectively O
as O
the O
full O
- O
length O
protein O
, O
but O
the O
PD B
alone O
or O
Pax B
- I
6 I
( I
5a I
) I
, O
a O
splice O
variant O
with O
an O
altered O
PD B
affecting O
its O
DNA O
binding O
specificity O
, O
did O
not O
. O

Amino O
- O
terminal O
polymorphisms O
of O
the O
human B
beta I
2 I
- I
adrenergic I
receptor I
impart O
distinct O
agonist O
- O
promoted O
regulatory O
properties O
. O

Gene B
GPR I
51 I
was O
localized O
by O
radiation O
hybrid O
mapping O
to O
chromosome O
9 O
, O
4 O
. O
81 O
cR O
from O
the O
WI O
- O
8684 O
marker O
, O
and O
proximal O
to O
the O
hereditary B
sensory I
neuropathy I
type I
1 I
locus I
. O

The O
expression O
of O
the O
leukocyte B
EL I
- I
246 I
antigen I
was O
regulated O
in O
the O
same O
manner O
as O
L B
- I
selectin I
and O
EL B
- I
246 I
recognized O
anti B
- I
L I
- I
selectin I
mAb I
affinity O
- O
purified O
antigen O
in O
SDS O
/ O
PAGE O
Western O
blot O
analysis O
. O

These O
operons O
encode O
subunits O
of O
photosystems B
I I
( O
psa B
) O
and O
II O
( O
psb B
) O
, O
the O
cytochrome B
bGf I
complex I
( O
pet B
) O
, O
the O
plastid O
NAD B
( I
P I
) I
H I
dehydrogenase I
( O
ndh B
) O
, O
and O
the O
unidentified O
open O
reading O
frame O
ycf9 B
. O

Acanthamoeba B
myosin I
I I
heavy I
chain I
kinase I
( O
MIHCK B
) O
phosphorylates O
the O
heavy O
chains O
of O
amoeba B
myosins I
I I
, O
increasing O
their O
actin B
- O
activated O
ATPase B
activities O
. O

In O
marked O
contrast O
to O
the O
previously O
published O
human B
CD6 I
sequence I
, O
the O
mouse O
sequence O
predicts O
a O
long O
cytoplasmic O
tail O
that O
is O
not O
closely O
related O
to O
other O
proteins O
and O
possesses O
two O
proline O
- O
rich O
motifs O
containing O
the O
SH3 B
- I
domain I
binding I
consensus I
sequence I
, O
three O
protein B
kinase I
C I
phosphorylation I
site I
motifs I
, O
nine O
casein B
kinase I
- I
2 I
phosphorylation I
site I
motifs I
, O
and O
a O
serine O
- O
threonine O
- O
rich O
motif O
repeated O
three O
times O
. O

In O
marked O
contrast O
to O
the O
previously O
published O
human B
CD6 I
sequence I
, O
the O
mouse O
sequence O
predicts O
a O
long O
cytoplasmic O
tail O
that O
is O
not O
closely O
related O
to O
other O
proteins O
and O
possesses O
two O
proline O
- O
rich O
motifs O
containing O
the O
SH3 B
- I
domain I
binding I
consensus I
sequence I
, O
three O
protein B
kinase I
C I
phosphorylation I
site I
motifs I
, O
nine O
casein B
kinase I
- I
2 I
phosphorylation I
site I
motifs I
, O
and O
a O
serine O
- O
threonine O
- O
rich O
motif O
repeated O
three O
times O
. O

The O
ferric B
uptake I
regulation I
( O
fur B
) O
gene O
product O
participates O
in O
regulating O
expression O
of O
the O
manganese O
- O
and O
iron O
- O
containing O
superoxide B
dismutase I
genes I
of I
Escherichia I
coli I
. O

These O
include O
the O
genes O
, O
undefined B
1 I
( O
UD1 B
) O
, O
UD2 B
, O
and O
UD3 B
, O
each O
coding O
for O
proteins O
of O
unknown O
function O
, O
the O
ken B
gene I
encoding O
a O
new O
Kruppel B
- I
like I
putative I
transcription I
factor I
, O
the O
fly O
homologues O
of O
the O
mammalian B
mitochondrial I
trifunctional I
enzyme I
( O
thiolase B
) O
, O
and O
the O
TAR B
DNA I
- I
binding I
protein I
- I
43 I
( O
TBPH B
) O
, O
the O
first O
nonvertebrate O
member O
of O
the O
transmembrane B
4 I
superfamily I
( O
TM4SF B
) O
gene O
, O
a O
new O
homeodomain B
gene I
, O
and O
a O
gene O
coding O
for O

METHODS O
: O
The O
Die O
Deutsche O
Diabetes O
Dialyse O
Studie O
is O
a O
prospective O
randomized O
placebo O
- O
controlled O
trial O
that O
tests O
the O
hypothesis O
that O
atorvastatin O
, O
a O
hydroxymethyl B
- I
glutaryl I
coenzyme I
A I
reductase I
inhibitor O
, O
decreases O
the O
rate O
of O
cardiovascular O
mortality O
and O
of O
nonfatal O
myocardial O
infarction O
in O
patients O
with O
type O
2 O
diabetes O
who O
have O
been O
on O
hemodialysis O
treatment O
for O
no O
more O
than O
two O
years O
. O

Growth B
hormone I
exerts O
its O
effects O
on O
the O
ovarian O
follicular O
cycle O
directly O
or O
by O
local O
production O
of O
insulin B
- I
like I
growth I
factor I
1 I
( O
IGF B
- I
1 I
) O
. O

Oligomers O
corresponding O
to O
the O
region O
of O
the O
mlc B
- I
1 I
/ I
3 I
enhancer I
, O
which O
encompasses O
this O
conserved O
sequence O
, O
bound O
MEF B
- I
2 I
and O
competed O
for O
its O
binding O
to O
the O
mck B
enhancer O
. O

Similar O
tissue O
- O
specific O
patterns O
are O
observed O
with O
a O
fusion O
between O
the O
caufliflower B
mosaic I
virus I
35S I
RNA I
promotor I
and O
the O
GUS B
gene I
. O

In O
several O
steps O
we O
converted O
the O
retinoid O
specific O
response O
element O
of O
the O
human B
retinoic I
acid I
receptor I
beta I
promoter I
into O
the O
vitamin O
D O
/ O
retinoic O
acid O
response O
element O
of O
the O
human B
osteocalcin I
promoter I
. O

Influence O
of O
huanglian O
used O
in O
combination O
with O
huangqin O
and O
gancao O
on O
the O
erythrocytic O
osmotic O
fragilitas O
of O
experimental O
glucose B
- I
6 I
- I
phosphate I
dehydrogenase I
deficiency O
in O
rats O
] O
OBJECTIVE O
: O
To O
study O
the O
influence O
of O
common O
combination O
of O
Huanglian O
( O
Coptis O
chinensis O
) O
on O
the O
erythrocytic O
osmotic O
fragilitas O
of O
glucose B
- I
6 I
- I
phosphate I
dehydrogenase I
( O
G6PD B
) O
deficiency O
in O
rats O
. O

Influence O
of O
huanglian O
used O
in O
combination O
with O
huangqin O
and O
gancao O
on O
the O
erythrocytic O
osmotic O
fragilitas O
of O
experimental O
glucose B
- I
6 I
- I
phosphate I
dehydrogenase I
deficiency O
in O
rats O
] O
OBJECTIVE O
: O
To O
study O
the O
influence O
of O
common O
combination O
of O
Huanglian O
( O
Coptis O
chinensis O
) O
on O
the O
erythrocytic O
osmotic O
fragilitas O
of O
glucose B
- I
6 I
- I
phosphate I
dehydrogenase I
( O
G6PD B
) O
deficiency O
in O
rats O
. O

Promoter O
activity O
of O
the O
proliferating B
- I
cell I
nuclear I
antigen I
gene I
is O
associated O
with O
inducible O
CRE B
- I
binding I
proteins I
in O
interleukin B
2 I
- O
stimulated O
T O
lymphocytes O
. O

Upstream O
tissue B
inhibitor I
of I
metalloproteinases I
- I
1 I
( I
TIMP I
- I
1 I
) I
element I
- I
1 I
, O
a O
novel O
and O
essential O
regulatory O
DNA O
motif O
in O
the O
human B
TIMP I
- I
1 I
gene I
promoter I
, O
directly O
interacts O
with O
a O
30 O
- O
kDa O
nuclear O
protein O
. O

These O
aa O
residues O
correspond O
to O
codons O
59 O
and O
108 O
in O
the O
P B
. I
falciparum I
DHFR I
active I
site I
in O
which O
similar O
aa O
substitutions O
( O
Cys O
Arg O
- O
59 O
and O
Ser O
Asn O
- O
108 O
) O
are O
associated O
with O
pyrimethamine O
resistance O
. O

Thus O
G17 B
targets O
the O
c B
- I
fos I
promoter I
CArG I
sequence I
via O
Rho B
A I
- O
dependent O
pathways O
, O
and O
Rho B
A I
appears O
to O
play O
an O
important O
role O
in O
the O
regulation O
of O
the O
trophic O
action O
of O
G17 B
. O

